Head-To-Head Review: Bruker Corporation (BRKR) vs. Its Peers

Bruker Corporation (NASDAQ: BRKR) is one of 83 publicly-traded companies in the “Advanced Medical Equipment & Technology” industry, but how does it contrast to its rivals? We will compare Bruker Corporation to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, profitability, earnings, dividends and risk.

Volatility & Risk

Bruker Corporation has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500. Comparatively, Bruker Corporation’s rivals have a beta of 0.89, suggesting that their average share price is 11% less volatile than the S&P 500.

Profitability

This table compares Bruker Corporation and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bruker Corporation 9.65% 26.66% 10.47%
Bruker Corporation Competitors -327.74% -35.51% -12.38%

Earnings & Valuation

This table compares Bruker Corporation and its rivals gross revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Bruker Corporation $1.66 billion $275.00 million 31.29
Bruker Corporation Competitors $2.06 billion $438.96 million -75.61

Bruker Corporation’s rivals have higher revenue and earnings than Bruker Corporation. Bruker Corporation is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Dividends

Bruker Corporation pays an annual dividend of $0.16 per share and has a dividend yield of 0.5%. Bruker Corporation pays out 16.0% of its earnings in the form of a dividend. As a group, “Advanced Medical Equipment & Technology” companies pay a dividend yield of 0.9% and pay out 26.0% of their earnings in the form of a dividend.

Analyst Recommendations

This is a summary of current recommendations and price targets for Bruker Corporation and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bruker Corporation 2 8 3 0 2.08
Bruker Corporation Competitors 266 1847 3304 105 2.59

Bruker Corporation currently has a consensus price target of $26.00, suggesting a potential downside of 16.91%. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 5.79%. Given Bruker Corporation’s rivals stronger consensus rating and higher probable upside, analysts plainly believe Bruker Corporation has less favorable growth aspects than its rivals.

Insider and Institutional Ownership

65.7% of Bruker Corporation shares are held by institutional investors. Comparatively, 51.1% of shares of all “Advanced Medical Equipment & Technology” companies are held by institutional investors. 35.2% of Bruker Corporation shares are held by company insiders. Comparatively, 18.7% of shares of all “Advanced Medical Equipment & Technology” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Bruker Corporation beats its rivals on 8 of the 15 factors compared.

About Bruker Corporation

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

What are top analysts saying about Bruker Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Bruker Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit